Corey M. McCann, MD, PhD, is the President and CEO of Pear Therapeutics, a pioneer in prescription digital therapeutics, as the first company to receive market authorization for software to treat disease. Previously, Corey was an investor with MPM Capital, an Engagement Manager with...
Read More →